15,337
Total Publications
909,506
Total Citations
Top Researchers
- Giancarlo D’Ambrosio 46,642 citations • 158 papers
- Benedicto Crespo‐Facorro 32,450 citations • 718 papers
- Fernando Rivera 25,396 citations • 252 papers
- María Martínez 22,984 citations • 259 papers
- Javier Crespo 21,458 citations • 884 papers
- Ricardo Blanco 19,797 citations • 1075 papers
- Ignacio Mateo 17,489 citations • 101 papers
- Ignacio Durán 16,915 citations • 344 papers
- Julio Pascual 16,657 citations • 562 papers
- Matilde Navarro 16,284 citations • 127 papers
Most Cited Papers
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial 2018 • 5,330 citations
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer 2008 • 3,688 citations
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms 2022 • 3,502 citations
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2019 • 3,140 citations
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer 2020 • 2,833 citations
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease 2009 • 2,257 citations
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 2018 • 1,981 citations
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study 2010 • 1,798 citations
- Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 2003 • 1,691 citations
- Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells 1999 • 1,649 citations